LIST OF TABLES
TABLE 01.GLOBAL TELMISARTAN MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 02.TELMISARTAN MARKET FOR HYPERTENSION, BY REGION, 2019-2027 ($MILLION)
TABLE 03.TELMISARTAN MARKET FOR CARDIOVASCULAR RISK REDUCTION, BY REGION, 2019-2027 ($MILLION)
TABLE 04.TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 05.HOSPITAL PHARMACIES TELMISARTAN MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 06.DRUG STORES AND RETAIL PHARMACIES TELMISARTAN MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 07.ONLINE PHARMACIES TELMISARTAN MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 08.TELMISARTAN MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 09.NORTH AMERICA TELMISARTAN MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 10.U.S. TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 11.U.S. TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 12.CANADA TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 13.CANADA TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 14.MEXICO TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 15.MEXICO TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 16.NORTH AMERICA TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 17.NORTH AMERICA TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 18.EUROPE TELMISARTAN MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 19.GERMANY TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 20.GERMANY TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 21.FRANCE TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 22.FRANCE TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 23.UK TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 24.UK TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 25.ITALY TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 26.ITALY TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 27.SPAIN TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 28.SPAIN TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 29.REST OF EUROPE TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 30.REST OF EUROPE TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 31.EUROPE TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 32.EUROPE TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 33.ASIA-PACIFIC TELMISARTAN MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 34.JAPAN TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 35.JAPAN TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 36.CHINA TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 37.CHINA TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 38.AUSTRALIA TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 39.AUSTRALIA TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 40.INDIA TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 41.INDIA TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 42.SOUTH KOREA TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 43.SOUTH KOREA TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 44.REST OF ASIA-PACIFIC TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 45.REST OF ASIA-PACIFIC TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 46.ASIA-PACIFIC TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 47.ASIA-PACIFIC TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 48.LAMEA TELMISARTAN MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 49.BRAZIL TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 50.BRAZIL TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 51.SAUDI ARABIA TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 52.SAUDI ARABIA TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 53.SOUTH AFRICA TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 54.SOUTH AFRICA TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 55.REST OF LAMEA TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 56.REST OF LAMEA TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 57.LAMEA TELMISARTAN MARKET, BY INDICATION, 2019-2027
TABLE 58.LAMEA TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL, 2019-2027
TABLE 59.ABBOTT: COMPANY SNAPSHOT
TABLE 60.ABBOTT: OERATING SEGMENT
TABLE 61.ABBOTT: PRODUCT PORTFOLIO
TABLE 62.AUROBINDO: COMPANY SNAPSHOT
TABLE 63.AUROBINDO: PRODUCT PORTFOLIO
TABLE 64.BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 65.BOEHRINGER INGELHEIM: OPERATING SEGMENTS
TABLE 66.BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 01.CIPLA: COMPANY SNAPSHOT
TABLE 02.CIPLA: OPERATING SEGMENTS
TABLE 03.CIPLA: PRODUCT PORTFOLIO
TABLE 04.GSK: COMPANY SNAPSHOT
TABLE 05.GSK: OPERATING SEGMENTS
TABLE 06.GSK: PRODUCT PORTFOLIO
TABLE 07.MYLAN: COMPANY SNAPSHOT
TABLE 08.MYLAN: OPERATING BUSINESS SEGMENTS
TABLE 09.MYLAN: PRODUCT PORTFOLIO
TABLE 10.SANOFI: COMPANY SNAPSHOT
TABLE 11.SANOFI: OERATING SEGMENT
TABLE 12.SANOFI: PRODUCT PORTFOLIO
TABLE 13.SUN PHARMA: COMPANY SNAPSHOT
TABLE 14.SUN PHARMA: OPERATING SEGMENTS
TABLE 15.SUN PHARMA: PRODUCT PORTFOLIO
TABLE 16.TEVA: COMPANY SNAPSHOT
TABLE 17.TEVA: OPERATING SEGMENTS
TABLE 18.TEVA: PRODUCT PORTFOLIO
TABLE 19.ZYDUS: COMPANY SNAPSHOT
TABLE 20.ZYDUS: OPERATING SEGMENTS
TABLE 21.ZYDUS: PRODUCT PORTFOLIO
TABLE 22.ZYDUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURE
LIST OF FIGURES
FIGURE 01.GLOBAL TELMISARTAN MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 01.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 02.MODERATE BARGAINING POWER OF BUYERS
FIGURE 03.LOW THREAT OF SUBSTITUTES
FIGURE 04.HIGH THREAT OF NEW ENTRANTS
FIGURE 05.MODERATE INTENSITY OF RIVALRY
FIGURE 06.TOP PLAYER POSITIONING, 2019
FIGURE 07.IMPACT ANALYSIS
FIGURE 08.COMPARATIVE ANALYSIS OF TELMISARTAN MARKET FOR HYPERTENSION, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 09.COMPARATIVE ANALYSIS OF TELMISARTAN MARKET FOR CARDIOVASCULAR RISK REDUCTION, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 10.COMPARATIVE ANALYSIS OF HOSPITAL PHARMACIES TELMISARTAN MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 11.COMPARATIVE ANALYSIS OF DRUG STORES AND RETAIL PHARMACIES TELMISARTAN MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 12.COMPARATIVE ANALYSIS OF ONLINE PHARMACIES TELMISARTAN MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 13.ABBOTT: NET SALES, 2017-2019 ($MILLION)
FIGURE 14.ABBOTT: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 15.ABBOTT: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 16.AUROBINDO: NET SALES, 2018-2020 ($MILLION)
FIGURE 17.AUROBINDO: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 18.BOEHRINGER INGELHEIM: NET SALES, 2017-2019 ($MILLION)
FIGURE 19.BOEHRINGER INGELHEIM: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 20.BOEHRINGER INGELHEIM: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 01.CIPLA: NET SALES, 2017-2019 ($MILLION)
FIGURE 02.CIPLA: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 03.CIPLA: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 04.GSK: NET SALES, 2017-2019 ($MILLION)
FIGURE 05.GSK: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 06.GSK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 07.MYLAN: NET SALES, 2017-2019 ($MILLION)
FIGURE 08.MYLAN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 09.SANOFI.: NET SALES, 2017-2019 ($MILLION)
FIGURE 10.SANOFI: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 11.SANOFI: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 12.SUN PHARMA: NET SALES, 2018-2020 ($MILLION)
FIGURE 13.SUN PHARMA: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 14.TEVA: NET SALES, 2017-2019 ($MILLION)
FIGURE 15.TEVA: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 16.TEVA: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 17.ZYDUS: NET SALES, 2018-2020 ($MILLION)
FIGURE 18.ZYDUS: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 19.ZYDUS: REVENUE SHARE, BY REGION, 2020 (%)
